|
SMC6 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.6228000000007E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.018700E-04 |
| Normal-vs-Stage2 |
1.5286299999917E-05 |
| Normal-vs-Stage3 |
2.74609999995068E-06 |
| Normal-vs-Stage4 |
6.378200E-04 |
| Stage1-vs-Stage2 |
2.941900E-02 |
| Stage1-vs-Stage3 |
4.596300E-02 |
| Stage1-vs-Stage4 |
3.369400E-01 |
| Stage2-vs-Stage3 |
4.917200E-01 |
| Stage2-vs-Stage4 |
3.029800E-01 |
| Stage3-vs-Stage4 |
6.116200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.94350000000721E-05 |
| Normal-vs-AfricanAmerican |
2.286200E-02 |
| Normal-vs-Asian |
1.157200E-03 |
| Caucasian-vs-AfricanAmerican |
8.486600E-01 |
| Caucasian-vs-Asian |
7.724400E-01 |
| AfricanAmerican-vs-Asian |
7.094800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.75384999999695E-05 |
| Normal-vs-Female |
4.45629999999975E-05 |
| Male-vs-Female |
3.767800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.098700E-03 |
| Normal-vs-Age(41-60Yrs) |
6.94190000039008E-07 |
| Normal-vs-Age(61-80Yrs) |
3.92399999999959E-05 |
| Normal-vs-Age(81-100Yrs) |
1.365640E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.132300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.526100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.168600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.208200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.086200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.814200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.158000E-01 |
| Classical-VS-Follicular |
4.956200E-04 |
| Classical-VS-Other |
5.334800E-01 |
| Classical-VS-Normal |
5.774300E-04 |
| Tall-VS-Follicular |
1.306790E-01 |
| Tall-VS-Other |
7.493400E-01 |
| Tall-VS-Normal |
1.061570E-02 |
| Follicular-VS-Other |
6.146200E-01 |
| Follicular-VS-Normal |
5.90359999996792E-07 |
| Other-VS-Normal |
7.433700E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.6787500000004E-05 |
| Normal-vs-N1 |
3.426400E-04 |
| N0-vs-N1 |
9.797400E-01 |
|
|
